Reading the annual reports…

First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.

GE HealthCare Technologies Inc. (GEHC) financial health, profit and balance sheet · Scorvest

GEHC · Nasdaq · United States · X-Ray Apparatus & Tubes & Related Irradiation Apparatus

GE HealthCare Technologies Inc.

Chicago, IL · Fiscal year ends in December · Figures in USD

+ Add to watchlist Compare

In shortGE HealthCare Technologies Inc. is profitable, generates cash and carries moderate debt, with revenue growing (+4.8% last year).

Financial health

Solid

Built from five areas over the last five annual reports. Tap an area to see the figures behind it.

How is this score calculated? →

Profitability73

Operating marginShare of each sale left after running the business, before interest and tax.	13.4%	61/100
Net marginShare of each sale left as profit after every cost, interest and tax.	10.1%	60/100
Return on equityProfit earned on the money shareholders put in. Above 15% is strong.	22.1%	100/100
Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge.	10.6%	70/100

Weight in the score: 25%

Balance sheet48

Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash.	1.37×	48/100
Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted.	0.96×	58/100
Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable.	1.80×	63/100
Interest coverageHow many times operating profit covers interest. Below 2 is risky.	6.28×	46/100
Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress.	1.99	23/100

Weight in the score: 25%

Cash generation67

Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt.	7.3%	49/100
Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy.	0.72×	53/100
Years with positive free cash flow (last 5)	5 of 5	100/100

Weight in the score: 20%

Stability99
Profitable years (last 5) 5 of 5 100/100
Years of revenue decline (last 5) 0 of 4 100/100
Revenue growth volatility 2.5% 100/100
Operating margin volatility 1.3% 97/100
Weight in the score: 20%
Growth39
Revenue growth, 3-year average 4.0% 39/100
EPS growth, 3-year average 2.5% 38/100
Weight in the score: 10%

Profitable years (last 5)	5 of 5	100/100
Years of revenue decline (last 5)	0 of 4	100/100
Revenue growth volatility	2.5%	100/100
Operating margin volatility	1.3%	97/100

Revenue growth, 3-year average	4.0%	39/100
EPS growth, 3-year average	2.5%	38/100

Fiscal year 2025 · change vs prior year

Revenue: $20.6B; ▲ 4.8%
Net income: $2.1B; ▲ 4.6%
Free cash flow: $1.5B; ▼ 3.2%
Operating margin: 13.4%; +0.1 pts
Cash & investments: $4.5B; –
Total debt: $10.0B; ▲ 11.7%
Diluted EPS: $4.55; ▲ 4.8%
Return on equity: 22.1%; –

Trends

Annual figures as reported. Hover a bar or point for the exact value.

Revenue and net income

RevenueNet income

Margins

Statements

The last 5 fiscal years from the company's annual reports.

USD millions; negative values in parentheses.

Fiscal year	FY21	FY22	FY23	FY24	FY25
Revenue	17,585	18,341	19,552	19,672	20,625
Gross profit	7,174	7,179	7,922	8,205	8,248
Research & development	816	1,026	1,205	1,311	1,260
Selling, general & admin	3,563	3,631	4,282	4,269	4,225
Operating income	2,795	2,522	2,435	2,625	2,763
Interest expense	40	77	542	504	440
Pre-tax income	2,875	2,512	2,361	2,581	2,768
Income tax	600	563	743	531	614
Net income	2,247	1,916	1,568	1,993	2,084
Diluted EPS	$4.95	$4.22	$3.03	$4.34	$4.55
Diluted shares (millions)	454	454	458	459	458

Quarterly results

The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.

The last 8 quarters of GE HealthCare Technologies Inc. are included in the Investor plan. Try free for 7 days →

Risk checks

Altman Z'' score

1.99 Grey zone

Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.

Piotroski F-score

4/9

Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.

Positive net income: passed
Positive operating cash flow: passed
Return on assets improved: failed
Cash flow exceeds net income: failed
Long-term debt ratio fell: failed
Current ratio improved: passed
No share dilution: passed
Gross margin improved: failed
Asset turnover improved: failed

Sources

10-QPeriod ending Jun 30, 2026Filed Jul 29, 2026Open the report ↗
10-QPeriod ending Mar 31, 2026Filed Apr 29, 2026Open the report ↗
10-KPeriod ending Dec 31, 2025Filed Feb 4, 2026Open the report ↗
10-QPeriod ending Sep 30, 2025Filed Oct 29, 2025Open the report ↗
10-QPeriod ending Jun 30, 2025Filed Jul 30, 2025Open the report ↗
10-QPeriod ending Mar 31, 2025Filed Apr 30, 2025Open the report ↗
10-KPeriod ending Dec 31, 2024Filed Feb 13, 2025Open the report ↗
10-QPeriod ending Sep 30, 2024Filed Oct 30, 2024Open the report ↗